We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX

Delisted

OCDX was delisted on the 26th of May, 2022.

Back to rankings

170 hedge funds and large institutions have $4.38B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 59 increasing their positions, 50 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $1.23M | Put options by funds: $737K

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

20% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 40

18% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 50

5% more funds holding

Funds holding: 162 → 170 (+8)

13% less capital invested

Capital invested by funds: $5B → $4.38B (-$629M)

Holders
170
Holders Change
+8
Holders Change %
+4.94%
% of All Funds
2.68%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
48
Increased
59
Reduced
50
Closed
40
Calls
$1.23M
Puts
$737K
Net Calls
+$490K
Net Calls Change
+$867K

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$43.7M
2
AC
Armistice Capital
New York
+$40.1M
3
MF
Magnetar Financial
Illinois
+$33.5M
4
JP Morgan Chase
JP Morgan Chase
New York
+$28.8M
5
Deutsche Bank
Deutsche Bank
Germany
+$23.4M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$64.6M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$44.7M
3
APM
Avidity Partners Management
Texas
-$38.3M
4
Macquarie Group
Macquarie Group
Australia
-$29.4M
5
Jennison Associates
Jennison Associates
New York
-$26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
126
Allianz Asset Management
Germany
$300K -$216K -12,014 -43%
HA
127
Havens Advisors
New York
$299K – – –
Zurich Cantonal Bank
128
Zurich Cantonal Bank
Switzerland
$281K – – –
WSTAM
129
Wilbanks Smith & Thomas Asset Management
Virginia
$278K – – –
OAM
130
Oppenheimer Asset Management
New York
$269K +$58.7K +3,260 +29%
LCM
131
Laurion Capital Management
New York
$264K -$324K -18,010 -56%
VT
132
Vise Technologies
New York
$261K +$251K +13,976 New
Squarepoint
133
Squarepoint
New York
$255K +$246K +13,684 New
SEI Investments
134
SEI Investments
Pennsylvania
$249K +$46.2K +2,566 +25%
Victory Capital Management
135
Victory Capital Management
Texas
$248K -$13.4K -746 -5%
PCM
136
PenderFund Capital Management
British Columbia, Canada
$247K +$191K +10,600 New
BC
137
Bridgefront Capital
Texas
$246K +$237K +13,196 New
State Board of Administration of Florida Retirement System
138
State Board of Administration of Florida Retirement System
Florida
$228K – – –
RA
139
Rise Advisors
New York
$225K +$217K +12,039 New
Bank of Montreal
140
Bank of Montreal
Ontario, Canada
$207K -$8.12K -451 -4%
TI
141
Telemetry Investments
New York
$205K +$198K +11,000 New
BCM
142
Bayesian Capital Management
New York
$203K +$196K +10,900 New
CIBC Asset Management
143
CIBC Asset Management
Ontario, Canada
$192K – – –
CC
144
Centiva Capital
New York
$187K – – –
AIP
145
Ameritas Investment Partners
Nebraska
$174K – – –
MLICM
146
Metropolitan Life Insurance Company (MetLife)
New York
$149K -$428K -23,760 -75%
SG Americas Securities
147
SG Americas Securities
New York
$126K -$321K -17,822 -73%
State of Tennessee, Department of Treasury
148
State of Tennessee, Department of Treasury
Tennessee
$123K +$119K +6,614 New
SWM
149
Spire Wealth Management
Virginia
$88K +$70.6K +3,926 +507%
QT
150
Quantbot Technologies
New York
$72K +$70.2K +3,900 New
4 5
6
7 8

OCDX Hedge Fund Activity: Q1 2022 in Review

170 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q1 2022, worth a combined $4.38B — down 13% from $5B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new OCDX positions and 40 closed out — a net gain of 8 holders — while 59 added to existing stakes and 50 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $43.7M. The largest seller was Janus Henderson Group, cutting an estimated $64.6M.

  • 170 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q1 2022, up from 162 in Q4 2021.
  • Funds reported $4.38B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q1 2022, down 13% quarter-over-quarter.
  • 48 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q1 2022 and 40 closed out, a net change of +8 holders.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q1 2022 was Farallon Capital Management, an estimated $43.7M added.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q1 2022 was Janus Henderson Group, an estimated $64.6M sold.

Based on aggregated 13F filings for Q1 2022.